0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Noninvasive Prenatal Gene Testing Technology Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-25Q11760
Home | Market Reports | Health| Reproductive Health
Global Noninvasive Prenatal Gene Testing Technology Market Research Report 2022
BUY CHAPTERS

Global Noninvasive Prenatal Gene Testing Technology Market Research Report 2024

Code: QYRE-Auto-25Q11760
Report
April 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Noninvasive Prenatal Gene Testing Technology Market

The global Noninvasive Prenatal Gene Testing Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Noninvasive Prenatal Gene Testing Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Noninvasive Prenatal Gene Testing Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Noninvasive Prenatal Gene Testing Technology in Chromosomal Abnormalities is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Noninvasive Prenatal Gene Testing Technology include Illumina, Natera, LifeLabs, NiftyTest, Labcorp, Xcelom, Veritas, Sema4 and CeGaT, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Noninvasive Prenatal Gene Testing Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Noninvasive Prenatal Gene Testing Technology.

Report Scope

The Noninvasive Prenatal Gene Testing Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Noninvasive Prenatal Gene Testing Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Noninvasive Prenatal Gene Testing Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Noninvasive Prenatal Gene Testing Technology Market Report

Report Metric Details
Report Name Noninvasive Prenatal Gene Testing Technology Market
Segment by Type
  • NIPT
  • NIPT Plus
Segment by Application
  • Chromosomal Abnormalities
  • Assisted Reproduction
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Natera, LifeLabs, NiftyTest, Labcorp, Xcelom, Veritas, Sema4, CeGaT, BGI, Berry Genomics, Daan Gene, CapitalBio, Annoroad, Adicon
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Noninvasive Prenatal Gene Testing Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Noninvasive Prenatal Gene Testing Technology Market report?

Ans: The main players in the Noninvasive Prenatal Gene Testing Technology Market are Illumina, Natera, LifeLabs, NiftyTest, Labcorp, Xcelom, Veritas, Sema4, CeGaT, BGI, Berry Genomics, Daan Gene, CapitalBio, Annoroad, Adicon

What are the Application segmentation covered in the Noninvasive Prenatal Gene Testing Technology Market report?

Ans: The Applications covered in the Noninvasive Prenatal Gene Testing Technology Market report are Chromosomal Abnormalities, Assisted Reproduction, Others

What are the Type segmentation covered in the Noninvasive Prenatal Gene Testing Technology Market report?

Ans: The Types covered in the Noninvasive Prenatal Gene Testing Technology Market report are NIPT, NIPT Plus

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NIPT
1.2.3 NIPT Plus
1.3 Market by Application
1.3.1 Global Noninvasive Prenatal Gene Testing Technology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Chromosomal Abnormalities
1.3.3 Assisted Reproduction
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Noninvasive Prenatal Gene Testing Technology Market Perspective (2019-2030)
2.2 Noninvasive Prenatal Gene Testing Technology Growth Trends by Region
2.2.1 Global Noninvasive Prenatal Gene Testing Technology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Noninvasive Prenatal Gene Testing Technology Historic Market Size by Region (2019-2024)
2.2.3 Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Region (2025-2030)
2.3 Noninvasive Prenatal Gene Testing Technology Market Dynamics
2.3.1 Noninvasive Prenatal Gene Testing Technology Industry Trends
2.3.2 Noninvasive Prenatal Gene Testing Technology Market Drivers
2.3.3 Noninvasive Prenatal Gene Testing Technology Market Challenges
2.3.4 Noninvasive Prenatal Gene Testing Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Noninvasive Prenatal Gene Testing Technology Players by Revenue
3.1.1 Global Top Noninvasive Prenatal Gene Testing Technology Players by Revenue (2019-2024)
3.1.2 Global Noninvasive Prenatal Gene Testing Technology Revenue Market Share by Players (2019-2024)
3.2 Global Noninvasive Prenatal Gene Testing Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Noninvasive Prenatal Gene Testing Technology Revenue
3.4 Global Noninvasive Prenatal Gene Testing Technology Market Concentration Ratio
3.4.1 Global Noninvasive Prenatal Gene Testing Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Noninvasive Prenatal Gene Testing Technology Revenue in 2023
3.5 Noninvasive Prenatal Gene Testing Technology Key Players Head office and Area Served
3.6 Key Players Noninvasive Prenatal Gene Testing Technology Product Solution and Service
3.7 Date of Enter into Noninvasive Prenatal Gene Testing Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Noninvasive Prenatal Gene Testing Technology Breakdown Data by Type
4.1 Global Noninvasive Prenatal Gene Testing Technology Historic Market Size by Type (2019-2024)
4.2 Global Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Type (2025-2030)
5 Noninvasive Prenatal Gene Testing Technology Breakdown Data by Application
5.1 Global Noninvasive Prenatal Gene Testing Technology Historic Market Size by Application (2019-2024)
5.2 Global Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Noninvasive Prenatal Gene Testing Technology Market Size (2019-2030)
6.2 North America Noninvasive Prenatal Gene Testing Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2019-2024)
6.4 North America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Noninvasive Prenatal Gene Testing Technology Market Size (2019-2030)
7.2 Europe Noninvasive Prenatal Gene Testing Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Noninvasive Prenatal Gene Testing Technology Market Size by Country (2019-2024)
7.4 Europe Noninvasive Prenatal Gene Testing Technology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size (2019-2030)
8.2 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size by Region (2019-2024)
8.4 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Noninvasive Prenatal Gene Testing Technology Market Size (2019-2030)
9.2 Latin America Noninvasive Prenatal Gene Testing Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2019-2024)
9.4 Latin America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size (2019-2030)
10.2 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size by Country (2019-2024)
10.4 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Noninvasive Prenatal Gene Testing Technology Introduction
11.1.4 Illumina Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Natera
11.2.1 Natera Company Detail
11.2.2 Natera Business Overview
11.2.3 Natera Noninvasive Prenatal Gene Testing Technology Introduction
11.2.4 Natera Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.2.5 Natera Recent Development
11.3 LifeLabs
11.3.1 LifeLabs Company Detail
11.3.2 LifeLabs Business Overview
11.3.3 LifeLabs Noninvasive Prenatal Gene Testing Technology Introduction
11.3.4 LifeLabs Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.3.5 LifeLabs Recent Development
11.4 NiftyTest
11.4.1 NiftyTest Company Detail
11.4.2 NiftyTest Business Overview
11.4.3 NiftyTest Noninvasive Prenatal Gene Testing Technology Introduction
11.4.4 NiftyTest Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.4.5 NiftyTest Recent Development
11.5 Labcorp
11.5.1 Labcorp Company Detail
11.5.2 Labcorp Business Overview
11.5.3 Labcorp Noninvasive Prenatal Gene Testing Technology Introduction
11.5.4 Labcorp Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.5.5 Labcorp Recent Development
11.6 Xcelom
11.6.1 Xcelom Company Detail
11.6.2 Xcelom Business Overview
11.6.3 Xcelom Noninvasive Prenatal Gene Testing Technology Introduction
11.6.4 Xcelom Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.6.5 Xcelom Recent Development
11.7 Veritas
11.7.1 Veritas Company Detail
11.7.2 Veritas Business Overview
11.7.3 Veritas Noninvasive Prenatal Gene Testing Technology Introduction
11.7.4 Veritas Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.7.5 Veritas Recent Development
11.8 Sema4
11.8.1 Sema4 Company Detail
11.8.2 Sema4 Business Overview
11.8.3 Sema4 Noninvasive Prenatal Gene Testing Technology Introduction
11.8.4 Sema4 Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.8.5 Sema4 Recent Development
11.9 CeGaT
11.9.1 CeGaT Company Detail
11.9.2 CeGaT Business Overview
11.9.3 CeGaT Noninvasive Prenatal Gene Testing Technology Introduction
11.9.4 CeGaT Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.9.5 CeGaT Recent Development
11.10 BGI
11.10.1 BGI Company Detail
11.10.2 BGI Business Overview
11.10.3 BGI Noninvasive Prenatal Gene Testing Technology Introduction
11.10.4 BGI Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.10.5 BGI Recent Development
11.11 Berry Genomics
11.11.1 Berry Genomics Company Detail
11.11.2 Berry Genomics Business Overview
11.11.3 Berry Genomics Noninvasive Prenatal Gene Testing Technology Introduction
11.11.4 Berry Genomics Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.11.5 Berry Genomics Recent Development
11.12 Daan Gene
11.12.1 Daan Gene Company Detail
11.12.2 Daan Gene Business Overview
11.12.3 Daan Gene Noninvasive Prenatal Gene Testing Technology Introduction
11.12.4 Daan Gene Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.12.5 Daan Gene Recent Development
11.13 CapitalBio
11.13.1 CapitalBio Company Detail
11.13.2 CapitalBio Business Overview
11.13.3 CapitalBio Noninvasive Prenatal Gene Testing Technology Introduction
11.13.4 CapitalBio Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.13.5 CapitalBio Recent Development
11.14 Annoroad
11.14.1 Annoroad Company Detail
11.14.2 Annoroad Business Overview
11.14.3 Annoroad Noninvasive Prenatal Gene Testing Technology Introduction
11.14.4 Annoroad Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.14.5 Annoroad Recent Development
11.15 Adicon
11.15.1 Adicon Company Detail
11.15.2 Adicon Business Overview
11.15.3 Adicon Noninvasive Prenatal Gene Testing Technology Introduction
11.15.4 Adicon Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
11.15.5 Adicon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of NIPT
    Table 3. Key Players of NIPT Plus
    Table 4. Global Noninvasive Prenatal Gene Testing Technology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Noninvasive Prenatal Gene Testing Technology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Noninvasive Prenatal Gene Testing Technology Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Noninvasive Prenatal Gene Testing Technology Market Share by Region (2019-2024)
    Table 8. Global Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Noninvasive Prenatal Gene Testing Technology Market Share by Region (2025-2030)
    Table 10. Noninvasive Prenatal Gene Testing Technology Market Trends
    Table 11. Noninvasive Prenatal Gene Testing Technology Market Drivers
    Table 12. Noninvasive Prenatal Gene Testing Technology Market Challenges
    Table 13. Noninvasive Prenatal Gene Testing Technology Market Restraints
    Table 14. Global Noninvasive Prenatal Gene Testing Technology Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Noninvasive Prenatal Gene Testing Technology Market Share by Players (2019-2024)
    Table 16. Global Top Noninvasive Prenatal Gene Testing Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Prenatal Gene Testing Technology as of 2023)
    Table 17. Ranking of Global Top Noninvasive Prenatal Gene Testing Technology Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Noninvasive Prenatal Gene Testing Technology Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Noninvasive Prenatal Gene Testing Technology Product Solution and Service
    Table 21. Date of Enter into Noninvasive Prenatal Gene Testing Technology Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Noninvasive Prenatal Gene Testing Technology Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Noninvasive Prenatal Gene Testing Technology Revenue Market Share by Type (2019-2024)
    Table 25. Global Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Noninvasive Prenatal Gene Testing Technology Revenue Market Share by Type (2025-2030)
    Table 27. Global Noninvasive Prenatal Gene Testing Technology Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Noninvasive Prenatal Gene Testing Technology Revenue Market Share by Application (2019-2024)
    Table 29. Global Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Noninvasive Prenatal Gene Testing Technology Revenue Market Share by Application (2025-2030)
    Table 31. North America Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Noninvasive Prenatal Gene Testing Technology Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Noninvasive Prenatal Gene Testing Technology Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Illumina Company Detail
    Table 47. Illumina Business Overview
    Table 48. Illumina Noninvasive Prenatal Gene Testing Technology Product
    Table 49. Illumina Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 50. Illumina Recent Development
    Table 51. Natera Company Detail
    Table 52. Natera Business Overview
    Table 53. Natera Noninvasive Prenatal Gene Testing Technology Product
    Table 54. Natera Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 55. Natera Recent Development
    Table 56. LifeLabs Company Detail
    Table 57. LifeLabs Business Overview
    Table 58. LifeLabs Noninvasive Prenatal Gene Testing Technology Product
    Table 59. LifeLabs Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 60. LifeLabs Recent Development
    Table 61. NiftyTest Company Detail
    Table 62. NiftyTest Business Overview
    Table 63. NiftyTest Noninvasive Prenatal Gene Testing Technology Product
    Table 64. NiftyTest Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 65. NiftyTest Recent Development
    Table 66. Labcorp Company Detail
    Table 67. Labcorp Business Overview
    Table 68. Labcorp Noninvasive Prenatal Gene Testing Technology Product
    Table 69. Labcorp Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 70. Labcorp Recent Development
    Table 71. Xcelom Company Detail
    Table 72. Xcelom Business Overview
    Table 73. Xcelom Noninvasive Prenatal Gene Testing Technology Product
    Table 74. Xcelom Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 75. Xcelom Recent Development
    Table 76. Veritas Company Detail
    Table 77. Veritas Business Overview
    Table 78. Veritas Noninvasive Prenatal Gene Testing Technology Product
    Table 79. Veritas Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 80. Veritas Recent Development
    Table 81. Sema4 Company Detail
    Table 82. Sema4 Business Overview
    Table 83. Sema4 Noninvasive Prenatal Gene Testing Technology Product
    Table 84. Sema4 Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 85. Sema4 Recent Development
    Table 86. CeGaT Company Detail
    Table 87. CeGaT Business Overview
    Table 88. CeGaT Noninvasive Prenatal Gene Testing Technology Product
    Table 89. CeGaT Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 90. CeGaT Recent Development
    Table 91. BGI Company Detail
    Table 92. BGI Business Overview
    Table 93. BGI Noninvasive Prenatal Gene Testing Technology Product
    Table 94. BGI Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 95. BGI Recent Development
    Table 96. Berry Genomics Company Detail
    Table 97. Berry Genomics Business Overview
    Table 98. Berry Genomics Noninvasive Prenatal Gene Testing Technology Product
    Table 99. Berry Genomics Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 100. Berry Genomics Recent Development
    Table 101. Daan Gene Company Detail
    Table 102. Daan Gene Business Overview
    Table 103. Daan Gene Noninvasive Prenatal Gene Testing Technology Product
    Table 104. Daan Gene Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 105. Daan Gene Recent Development
    Table 106. CapitalBio Company Detail
    Table 107. CapitalBio Business Overview
    Table 108. CapitalBio Noninvasive Prenatal Gene Testing Technology Product
    Table 109. CapitalBio Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 110. CapitalBio Recent Development
    Table 111. Annoroad Company Detail
    Table 112. Annoroad Business Overview
    Table 113. Annoroad Noninvasive Prenatal Gene Testing Technology Product
    Table 114. Annoroad Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 115. Annoroad Recent Development
    Table 116. Adicon Company Detail
    Table 117. Adicon Business Overview
    Table 118. Adicon Noninvasive Prenatal Gene Testing Technology Product
    Table 119. Adicon Revenue in Noninvasive Prenatal Gene Testing Technology Business (2019-2024) & (US$ Million)
    Table 120. Adicon Recent Development
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Noninvasive Prenatal Gene Testing Technology Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Noninvasive Prenatal Gene Testing Technology Market Share by Type: 2023 VS 2030
    Figure 3. NIPT Features
    Figure 4. NIPT Plus Features
    Figure 5. Global Noninvasive Prenatal Gene Testing Technology Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Noninvasive Prenatal Gene Testing Technology Market Share by Application: 2023 VS 2030
    Figure 7. Chromosomal Abnormalities Case Studies
    Figure 8. Assisted Reproduction Case Studies
    Figure 9. Others Case Studies
    Figure 10. Noninvasive Prenatal Gene Testing Technology Report Years Considered
    Figure 11. Global Noninvasive Prenatal Gene Testing Technology Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Noninvasive Prenatal Gene Testing Technology Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Noninvasive Prenatal Gene Testing Technology Market Share by Region: 2023 VS 2030
    Figure 14. Global Noninvasive Prenatal Gene Testing Technology Market Share by Players in 2023
    Figure 15. Global Top Noninvasive Prenatal Gene Testing Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Prenatal Gene Testing Technology as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Noninvasive Prenatal Gene Testing Technology Revenue in 2023
    Figure 17. North America Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Noninvasive Prenatal Gene Testing Technology Market Share by Country (2019-2030)
    Figure 19. United States Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Noninvasive Prenatal Gene Testing Technology Market Share by Country (2019-2030)
    Figure 23. Germany Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Share by Region (2019-2030)
    Figure 31. China Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Noninvasive Prenatal Gene Testing Technology Market Share by Country (2019-2030)
    Figure 39. Mexico Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Share by Country (2019-2030)
    Figure 43. Turkey Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Illumina Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 46. Natera Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 47. LifeLabs Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 48. NiftyTest Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 49. Labcorp Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 50. Xcelom Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 51. Veritas Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 52. Sema4 Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 53. CeGaT Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 54. BGI Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 55. Berry Genomics Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 56. Daan Gene Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 57. CapitalBio Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 58. Annoroad Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 59. Adicon Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2019-2024)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS